(Q54231752)

26 May 2018

title

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects. (English)

1 reference

26 May 2018

1 reference

1 reference

Vorobioff J

1

1 reference

26 May 2018

Picabea E

2

1 reference

26 May 2018

Gamen M

3

1 reference

26 May 2018

Villavicencio R

4

1 reference

26 May 2018

Bordato J

5

1 reference

26 May 2018

Bessone F

6

1 reference

26 May 2018

Tanno H

7

1 reference

26 May 2018

Palazzi J

8

1 reference

26 May 2018

Sarano H

9

1 reference

26 May 2018

Pozzoli L

10

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 September 1993

1 reference

26 May 2018

published in

Hepatology

1 reference

26 May 2018

volume

18

1 reference

26 May 2018

issue

3

1 reference

26 May 2018

page(s)

477-484

1 reference

26 May 2018

Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Portal hemodynamics during nitroglycerin administration in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Pathogenesis of ascites formation and hepatorenal syndrome: humoral and hemodynamic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840180302

7 January 2021

Identifiers

DOI

10.1002/HEP.1840180302

1 reference

26 May 2018

PubMed ID

8359793

1 reference

26 May 2018